Continuous monitoring of blood sugar without the blood of the finger, in the Abbott "instantaneous sense" foreign companies have achieved the same effect
Release date: 2017-11-02
Measuring blood sugar is a prescribed action for diabetics. The method of detecting blood sugar is the most common. In the domestic market, hundreds of blood glucose meter brands, whether it is a traditional blood glucose meter or an intelligent blood glucose meter, basically adopt this detection method. However, the limitation of this method is that only the blood glucose level at a certain time point can be detected, rather than the fluctuation of continuous blood glucose, and the help for reflecting the actual situation of the patient is limited.
As a result, Abbott’s “instantaneous†blood glucose meter, which monitors continuous blood glucose, is available. Once launched, it is very popular among people with diabetes in China. In China, only a few medical device manufacturers such as San Médino have the ability to develop and produce continuous blood glucose monitoring equipment.
Our recent interview with Youzhi Sugar and San Médino jointly developed a new generation of continuous blood glucose monitoring equipment, and provided an integrated monitoring and management service based on data cloud architecture for diabetic patients. Uygur not only defines itself as a manufacturer of medical instruments, but also sees the greater value of the diabetes management services behind it.
The patient only needs to wear the host of the special medicine sugar on the upper arm to perform continuous blood glucose monitoring, and the monitoring can be up to ten days each time. The working principle is to form an electrical signal through a sensor that penetrates into the skin and penetrate into the tissue fluid of the patient to oxidize with glucose. The electrical signal is then converted into a blood glucose reading, which is then transmitted to the wireless receiver through the host. This technology can understand the patient's 24-hour blood glucose fluctuations, and the process of wearing monitoring equipment is basically painless. At the same time, Yumao Sugar also integrates exercise and sleep monitoring, reflecting the relationship between daily habits and blood sugar changes in a multi-dimensional manner, helping doctors to develop reasonable medication and management programs for patients.
Song Lin, founder of You Medicine Sugar, said that continuous blood glucose monitoring can be applied to the following groups of people with diabetes:
Real-time monitoring in the hospital:
For preoperative and postoperative patients and critically ill patients with emergency sugar control. Medtronic's continuous blood glucose monitoring products are the mainstay of this market and have a good market share in China. But its products need to be matched with insulin pumps, which are more expensive. Youyi Sugar can serve patients at a more reasonable price.
Remote management outside the hospital:
It is used for doctors to monitor the real-time blood glucose monitoring of patients with non-compliance with blood glucose management outside the hospital, gestational diabetes, and regular review of the majority of diabetic patients, and adjust the sugar control program.
Pre-sugar crowd screening:
Youyi Sugar also targeted the market for some of the groups that were ignored by the hospital – the pre-sugar population. Before being diagnosed with diabetes, some high-risk groups can prevent the development of diabetes if they can be managed in advance, but these groups are not responsible for the hospital, and they are rarely aware of the risk. . The Uygur Medicine Program plans to promote early screening services for diabetes through this group of senior executives, and to intervene in intervention management services for those who are already at high risk.
Uygur Sugar uses wearable instrument monitoring, relying on the massive data processing capabilities of the Internet and cloud platform to create a chronic disease management service platform, combining early screening for chronic diseases, customized treatment programs in hospitals, and self-behavior interventions outside the hospital to make doctors more intuitive. And efficient diagnosis, allowing patients to be safer and more comfortable treatment.
Although Yumao Sugar emphasizes its own chronic disease management services, from the current market situation, Song Lin said that the sales of blood glucose meter equipment and consumables is still its main profit model, and the habit of paying patients for chronic disease management services remains to be seen. Gradually develop.
It is understood that the continuous blood glucose monitor developed by U-Sugar and Semillon at the end of this year will be certified by CFDA and officially promoted to the hospital market. The second generation of products independently developed by Yumao Sugar is expected to be approved by the CDFA next year. In marketing, Yumao Sugar will enter community hospitals and large hospitals through channels, and expand to the C-end market through physical examination institutions and health management centers.
On the team side, Song Lin, founder of Youzhi Sugar, has 15 years of experience in the Internet and telecommunications industry. He used to be vice president of KongZhong; co-founder Yi Jiang is a senior investor; technical director once served as technical director of KONG.NET and CTO of eggshell network. More than 10 years of experience in the Internet, mobile portal, data analysis and server-side architecture.
In 2014, Youshou Sugar received a $6 million angel round of financing and is currently undergoing Pre-A round of financing.
Source: 36æ°ª
Medical Turn Reducer,Medical Switch Trocar,Stainless Steel Trocar,Stainless Steel Magnetic Trocar
ZHEJIANG SHENDASIAO MEDICAL INSTRUMENT CO.,LTD. , https://www.shendasiaomed.com